rhenium(V)dimercaptosuccinic acid

a possible tumor radiotherapy agent; RN given is for unlabeled cpd; a beta-emitting radiopharmaceutical

Also Known As:

186 Re-DMSA; 188 Re-DMSA; Re(V)DMSA; rhenium DMSA; rhenium(V)dimercaptosuccinic acid, 186Re-labeled

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasm Metastasis (Metastasis) 04/01/2004 - "The vignettes illustrated in the present article demonstrate avid (99)Tc(m)(V)DMSA concentration in skeletal metastases from a wide variety of malignancies and thus expand the potential therapeutic indications for 188/186 Re(V)DMSA. " 09/01/2000 - "Rhenium-188 dimercaptosuccinic acid complex [(188)Re(V)DMSA], a potential therapeutic analogue of the tumour imaging agent (99m)Tc(V)DMSA, is selectively taken up in bone metastases in patients with prostate cancer. "
2.	Prostatic Neoplasms (Prostate Cancer) 09/01/2000 - "(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone." 09/01/2000 - "Rhenium-188 dimercaptosuccinic acid complex [(188)Re(V)DMSA], a potential therapeutic analogue of the tumour imaging agent (99m)Tc(V)DMSA, is selectively taken up in bone metastases in patients with prostate cancer. "
3.	Neoplasms (Cancer) 04/01/2004 - "The vignettes illustrated in the present article demonstrate avid (99)Tc(m)(V)DMSA concentration in skeletal metastases from a wide variety of malignancies and thus expand the potential therapeutic indications for 188/186 Re(V)DMSA. "

1.	Succimer (Dimercaptosuccinic Acid)
2.	Rhenium-188